http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1631735_PMID27328029

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440140563_AID1631735_PMID27328029_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440181961_AID1631735_PMID27328029_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID1631735_PMID27328029_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440149779_AID1631735_PMID27328029_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103405029_AID1631735_PMID27328029_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440223637_AID1631735_PMID27328029_VALUE6
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Reversal of P-gp-mediated resistance in adriamycin-resistant human HepG2 cells assessed as reduction in ADR IC50 at 100 nM after 48 hrs by MTT assay relative to control
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440149779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440223637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103405029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440140563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440181961
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1631735

Total number of triples: 17.